PACS Group (NYSE:PACS) Director Mark Hancock Sells 144,318 Shares of Stock

Posted by Francis Steltz on Sep 15th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) Director Mark Hancock sold 144,318 shares of the stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $44.57, for a total value of $6,432,253.26. Following the sale, the director directly owned 53,674,566 shares in the company, valued at $2,392,275,406.62. This trade represents a 0.27% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

On Tuesday, September 15th, Mark Hancock sold 155,682 shares of PACS Group stock. The shares were sold at an average price of $42.47, for a total value of $6,611,814.54.
On Thursday, July 9th, Mark Hancock sold 4,966 shares of PACS Group stock. The shares were sold at an average price of $45.06, for a total value of $223,767.96.
On Wednesday, July 8th, Mark Hancock sold 20,338 shares of PACS Group stock. The shares were sold at an average price of $45.07, for a total value of $916,633.66.
On Monday, July 6th, Mark Hancock sold 142,163 shares of PACS Group stock. The stock was sold at an average price of $45.33, for a total transaction of $6,444,248.79.
On Thursday, July 2nd, Mark Hancock sold 12,825 shares of PACS Group stock. The stock was sold at an average price of $45.01, for a total transaction of $577,253.25.
On Wednesday, July 1st, Mark Hancock sold 6,080 shares of PACS Group stock. The shares were sold at an average price of $45.02, for a total transaction of $273,721.60.
On Friday, June 26th, Mark Hancock sold 61,931 shares of PACS Group stock. The shares were sold at an average price of $40.50, for a total transaction of $2,508,205.50.
On Thursday, June 25th, Mark Hancock sold 138,069 shares of PACS Group stock. The shares were sold at an average price of $40.33, for a total transaction of $5,568,322.77.
On Wednesday, June 17th, Mark Hancock sold 63,680 shares of PACS Group stock. The stock was sold at an average price of $35.31, for a total transaction of $2,248,540.80.

PACS Group Price Performance

NYSE PACS traded down $2.54 on Tuesday, hitting $42.01. The stock had a trading volume of 1,011,870 shares, compared to its average volume of 905,184. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $49.49. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market capitalization of $6.65 billion, a price-to-earnings ratio of 24.42, a price-to-earnings-growth ratio of 1.40 and a beta of -0.13. The firm has a 50-day moving average of $44.74 and a 200-day moving average of $39.12.

PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. Equities analysts expect that PACS Group, Inc. will post 2.13 EPS for the current year.

Institutional Trading of PACS Group

A number of hedge funds have recently made changes to their positions in the stock. Tidal Investments LLC purchased a new position in PACS Group in the second quarter worth $252,000. Engineers Gate Manager LP purchased a new stake in PACS Group during the second quarter valued at about $1,132,000. Integrated Wealth Concepts LLC purchased a new stake in PACS Group during the second quarter valued at about $75,000. Squarepoint Ops LLC lifted its stake in PACS Group by 94.7% during the second quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock worth $2,538,000 after purchasing an additional 28,945 shares during the last quarter. Finally, Nykredit A S bought a new stake in PACS Group during the second quarter worth about $95,000.

Key Stories Impacting PACS Group

Here are the key news stories impacting PACS Group this week:

Positive Sentiment: Investor Steven Cress highlighted PACS Group as a highly rated stock he owns, reinforcing the bullish case for the skilled-nursing and post-acute-care operator. Behind The Portfolio: Why Steven Cress Owns This Top-Rated Stock
Positive Sentiment: Analyst sentiment remains favorable: PACS has a consensus “Moderate Buy” rating and an average price target of $58.80, above recent trading levels. Truist, Oppenheimer, UBS and JPMorgan have recently set targets ranging from $57 to $62. The company also exceeded second-quarter earnings and revenue expectations, reporting adjusted earnings of $0.63 per share versus the $0.54 consensus and revenue of $1.43 billion versus $1.41 billion.
Neutral Sentiment: PACS announced that CEO and Chairman Jason Murray, CFO Carey Hendrickson and COO Josh Jergensen will present at the Jefferies Healthcare Services and Technology Conference on September 15. Investors may look for updates on operations, growth plans and the company’s outlook. PACS Group to Present at the 2026 Jefferies Healthcare Services and Technology Conference
Negative Sentiment: CEO Jason Murray continued selling shares under a pre-arranged Rule 10b5-1 plan, including 317 shares at $45.03 and earlier sales of 10,529 shares at $45.23 and 8,771 shares at $45.16. The sales can weigh on sentiment, although they represent a very small portion of his roughly 54.6 million remaining shares and do not necessarily signal deteriorating business prospects. Insider Selling: PACS Group CEO Sells 317 Shares

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Royal Bank Of Canada lifted their price objective on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. UBS Group raised their price target on PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. JPMorgan Chase & Co. raised their price target on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a report on Friday, September 4th. Truist Financial set a $62.00 price target on PACS Group in a research report on Wednesday, September 2nd. Finally, Weiss Ratings lowered PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th. Five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, PACS Group currently has a consensus rating of “Moderate Buy” and an average price target of $58.80.

Read Our Latest Stock Analysis on PACS

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.